logo inner

Scientist II/Senior Scientist I - Nucleic Acid Detection

Mammoth BiosciencesMammoth Brisbane, California, United StatesOnsite
This job is no longer open
OPPORTUNITY
Mammoth’s Assay Development team is hiring a Scientist II/Sr. Scientist I to develop nucleic acid testing assays to support the development of novel CRISPR-based therapeutics. The successful candidate will develop, optimize, and routinely execute DNA and RNA quantification assays and contribute to de novo assay development. This position requires a strong background in plate based assays, excellent problem-solving skills, analytical thinking, and the ability to work collaboratively in a fast-paced environment.

KEY RESPONSIBILITIES


  • Contribute creatively to the design and development of novel assays for characterizing therapeutic nucleic acids for CRISPR-based therapies
  • Develop scalable and rigorous assays for measuring gene expression, RNA stability and degradation, pharmacokinetics, and therapeutic efficacy
  • Liaise with CROs to qualify and validate assays developed by the team
  • Routinely develop standardized protocols for assays
  • Plan, design, execute and designate assays for CRISPR therapeutic development
  • Provide consultation to other program teams on dPCR, ddPCR, qPCR, RNA-seq and other relevant assays routinely used in early research and later stage drug development
  • Train and provide instructions to junior members of assay development and associated teams on assays
  • Document experiments in electronic lab notebooks and present present data when needed
  • Provide support to automation team scientists to onboard protein detection protocols to high throughput systems
  • Lead team and routinely develop and improve processes to better team functionality

REQUIRED QUALIFICATIONS


  • PhD in Molecular Biology, Cell Biology, Biochemistry, Bioengineering, or related fields with 3+ years of relevant professional experience in industry or academia following completion of PhD. For non-PhD candidates, an MS degree with 6+ years of professional experience is required. 
  • At least 3 years of hands-on experience with digital PCR, qRT-PCR, droplet digital PCR, RNA-seq and other nucleic acid based molecular biology techniques
  • 2+ years of hands-on experience in at least two of the following areas: NAT assay validation and qualification; Design and implementation and novel DNA and RNA quantification methods; Generating robust standardized protocols and SOPs as release assays

PREFERRED QUALIFICATIONS


  • Background in transcriptome analyses, RNA-seq, single cell RNA-seq
  • Prior experience with CRO management
  • Prior experience filing INDs for gene therapies
  • Background knowledge of CRISPR-based gene editing therapies and modalities including insertions, base and prime editing, and epigenetic editing
  • 1+ years of experience managing direct reports
  • Working proficiency with common software and data analysis tools (Benchling, Excel, GraphPad Prism, JMP, Biorender)
  • Strong verbal and written communication skills
  • Active engagement with concepts of diversity and inclusion 

BENEFITS


  • Company-paid health/vision/dental benefits
  • Unlimited vacation and generous sick time
  • Company-sponsored meals and snacks
  • Wellness, caregiver and ergonomics benefits
  • 401(k) with company matching

Base Salary Range: $135,000 - $155,000Actual base salary will be determined by relevant professional experience, applicable skills, and internal equity.COMPANYMammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop long-term curative therapies, as well as other applications such as decentralized precision diagnostics. Founded by CRISPR pioneer and Nobel laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington, the company’s ultracompact proteins are designed to enable in vivo gene editing in difficult to reach tissues utilizing both nuclease applications and new editing modalities beyond double stranded breaks, including base editing, gene writing, and epigenetic editing.

The company is building out its pipeline of potential in vivo gene editing therapeutics and capabilities and has partnerships with leading pharmaceutical and biotechnology companies to broaden the reach of its innovative and proprietary technology. Mammoth’s deep science and industry experience, along with a robust and differentiated intellectual property portfolio, have enabled the company to further its mission to transform the lives of patients and deliver on the full promise of CRISPR technologies.It is our policy and intent to provide equal opportunity to all persons without regard to race, color, religion, political affiliation, sex/gender (including gender expression/identity, pregnancy, childbirth and related medical conditions), marital status, registered domestic partner status, sexual orientation, age, ancestry, national origin, veteran status, disability, medical condition, genetic characteristics, and/or any other basis protected by law.

This policy covers all facets of employment including, but not limited to: recruitment, selection, placement, promotions, transfers, demotions, terminations, training, and compensation.Mammoth Biosciences requires that all employees be vaccinated against COVID-19 as a condition of at-will employment, with exceptions for medical or religious reasons in compliance with local, state, and federal law. Apply for this job

This job is no longer open

Life at Mammoth Biosciences

Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. Mammoth aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13 and Cas14, Mammoth can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in San Francisco, Mammoth Biosciences is co-founded by CRISPR pioneer Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Mayfield, NFX, and 8VC, Decheng and leading individual investors including Brook Byers, Tim Cook, and Jeff Huber.
Thrive Here & What We Value- Unlimited vacation and generous sick time- Company-sponsored meals and snacks- Wellness, caregiver, and ergonomics benefits- 401(k) with company matching- Equal opportunity policy
Your tracker settings

We use cookies and similar methods to recognize visitors and remember their preferences. We also use them to measure ad campaign effectiveness, target ads and analyze site traffic. To learn more about these methods, including how to disable them, view our Cookie Policy or Privacy Policy.

By tapping `Accept`, you consent to the use of these methods by us and third parties. You can always change your tracker preferences by visiting our Cookie Policy.

logo innerThatStartupJob
Discover the best startup and their job positions, all in one place.
Copyright © 2024